Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

HCKT May 5, 2026

The Hackett Group Q1 2026 Earnings Call - Margin Inflection Expected in Q3 as AI Platform Transition Accelerates

The Hackett Group reported Q1 2026 revenues before reimbursements of $68.7 million, down 11% year-over-year, with adjusted EPS of $0.34 at the low end of guidance. The company is executing a strategic...

  • Q1 2026 revenues before reimbursements were $68.7 million, an 11% decline year-over-year, reflecting macro headwinds and elongated client decision cycles.
  • Adjusted EPS came in at $0.34, at the low end of guidance, as the company absorbs costs from its strategic AI transition.
  • The firm is aggressively migrating from labor-based services to an AI platform-enabled delivery model using proprietary tools like Hackett AI XPLR and the ZBrain agentic orchestration platform from LeewayHertz.
  • +11 more takeaways
CRCT May 5, 2026

Cricut Q1 2026 Earnings Call - Platform Revenue Growth Masks Product Revenue Decline

Cricut reported a 2% year-over-year revenue decline to $159.5 million in Q1 2026, driven by a 9.6% drop in product revenue as the company shifted to lower-priced, bundle-only machines. However, platfo...

  • Total revenue declined 2% year-over-year to $159.5 million, with product revenue falling 9.6% due to lower average selling prices and promotional activity.
  • Platform revenue grew nearly 6% year-over-year to $84.8 million, driven by a 3% increase in paid subscribers to 3.08 million and a 4.8% rise in ARPU.
  • Global machine sell-out units increased year-over-year, signaling strong consumer demand for new bundle-only offerings like the Joy 2 and Explore 5.
  • +10 more takeaways
TMDX May 5, 2026

TransMedics Q1 2026 Earnings Call - Revenue Growth Hits 21% as CHOPS and Gen 3.0 Drive Strategic Expansion

TransMedics delivered a solid Q1 2026 with total revenue of $174 million, up 21% year-over-year, driven by strong liver performance and growing OCS case volumes. The company is aggressively investing ...

  • Total revenue for Q1 2026 reached $174 million, representing 21% year-over-year growth and 8% sequential growth, led by strong liver performance and increased OCS case volumes.
  • U.S. transplant product revenue grew 22% year-over-year to $102 million, while international revenue surged 39% year-over-year to $6 million, driven by heart and lung adoption.
  • Adjusted operating profit of $18.1 million reflected a 10.4% operating margin, down from prior periods due to strategic investments in R&D and international expansion.
  • +7 more takeaways
RVLV May 5, 2026

Revolve Group Q1 2026 Earnings Call - Accelerating Growth and Strategic Investments Drive Market Share Gains

Revolve Group delivered a strong first quarter in 2026, with net sales rising 16% year-over-year to $343 million, marking its fastest growth rate in nearly four years. The company's strategic investme...

  • Net sales increased 16% year-over-year to $343 million, the highest growth rate in nearly four years, with a 5-point sequential improvement from Q4 2025.
  • Diluted earnings per share rose 25% year-over-year to $0.20, reflecting strong bottom-line performance despite increased marketing investments.
  • International net sales grew 20% year-over-year, marking the 13th consecutive quarter of international growth outpacing the U.S., despite a slowdown in the Middle East.
  • +7 more takeaways
DVA May 5, 2026

DaVita Q1 2026 Earnings Call - Raised Guidance on Volume Surge and Fresenius Transfers

DaVita delivered a sharp first quarter, beating expectations on revenue per treatment and cost discipline while quietly capturing market share from Fresenius clinic closures. The company lifted full-y...

  • Full-year adjusted operating income guidance raised to $2.15B-$2.25B, up $40M midpoint, driven by volume and labor efficiency.
  • Full-year adjusted EPS guidance lifted to $14.10-$15.20, reflecting higher volume and lower patient care costs.
  • Treatment volume guidance increased from flat to +25-50 basis points, with roughly half attributed to Fresenius clinic transfers.
  • +9 more takeaways
ACIC May 5, 2026

American Coastal Insurance Corporation Q1 2026 Earnings Call - Discipline Wins as Soft Market Pressures Rates But Margins Hold

American Coastal Insurance (ACIC) reported Q1 2026 net income of $19.3 million, driven by a 66% combined ratio that reflects sharp underwriting discipline in a rapidly softening commercial property ma...

  • Q1 2026 net income came in at $19.3 million, with core income also at $19.3 million, down $1.4 million year-over-year as net premium earned declined, though this was partially offset by lower total expenses.
  • The combined ratio stood at 66%, just 1 point higher than the prior year, while the non-GAAP underlying combined ratio was 68.3%, demonstrating stable underwriting margins despite a softening commercial property market.
  • CEO Bennett Bradford Martz confirmed average account rate decreases are distorting premium growth, but policy counts and exposure bases actually increased year-over-year, signaling strong account retention and market leadership defense.
  • +7 more takeaways
JOBY May 5, 2026

Joby Aviation Q1 2026 Earnings Call - EIPP Selection and Manufacturing Ramp Accelerate

Joby Aviation's Q1 2026 results underscore a critical inflection point in the eVTOL commercialization timeline. The company secured its spot in the White House-backed EIPP program across 11 states, en...

  • Joby selected for the White House-backed EIPP program across 11 states, including Texas, New York, and Florida, enabling pre-certification passenger operations this year.
  • Successful demonstration flights connected JFK to Manhattan heliports and operated within Class B airspace, proving operational maturity in dense urban environments.
  • Manufacturing is accelerating with parts being produced for the ninth conforming aircraft and a third shift added to composites and automated fiber placement teams.
  • +7 more takeaways
SSSS May 5, 2026

SuRo Capital Q1 2026 Earnings Call - NAV Surges 76% Amid Strategic Magnetar Partnership

SuRo Capital delivered its largest quarterly NAV increase in history, jumping 76% to $14.24 per share, driven by massive unrealized gains across a concentrated portfolio of high-growth private compani...

  • SuRo Capital’s NAV surged 76% quarter-over-quarter from $8.09 to $14.24 per share, marking the largest quarterly increase in company history.
  • The valuation jump was primarily driven by a $6.25 per share increase in unrealized appreciation across the portfolio, partially offset by a $0.16 per share net investment loss.
  • Top five holdings, including Whoop, OpenAI, and Vast Data, now represent approximately 72% of the investment portfolio, highlighting a highly concentrated strategy.
  • +7 more takeaways
LYV May 5, 2026

Live Nation Q1 2026 Earnings Call - Global Supply Surge and Venue Nation Expansion Offset Ticketing Headwinds

Live Nation reported a strong start to 2026, driven by a global expansion in concert supply and robust demand across all venue types. CEO Michael Rapino highlighted that the "pie" of touring activity ...

  • Global supply of touring artists is expanding rapidly, with strong growth across all venue types from clubs to stadiums, driven by international markets including Latin America, Asia, and K-pop acts.
  • Amphitheaters are rebounding strongly in 2026, with double-digit growth in show counts and ticket sales, offsetting last year’s supply-side stumbles and demonstrating resilient demand.
  • Venue Nation strategy is accelerating, with a focus on both building new venues and partnering with existing sports stadiums in Latin America to lock in revenue streams with lower capital intensity.
  • +7 more takeaways
KVYO May 5, 2026

Klaviyo Q1 2026 Earnings Call - AI Agents Drive Record Margins and Enterprise Consolidation

Klaviyo delivered a quarter that underscored the shift from basic marketing automation to autonomous consumer relationship management. Revenue grew 28% year-over-year to $358 million, while non-GAAP o...

  • Revenue grew 28% year-over-year to $358 million, beating expectations and driving a raise in full-year guidance.
  • Non-GAAP operating margin expanded to a record 16%, marking the highest level since the company went public.
  • Klaviyo achieved its first quarter of positive GAAP operating margin since its IPO, driven by margin expansion and reduced stock-based compensation.
  • +7 more takeaways